Y-MABS THERAPEUTICS, INC.

(YMAB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Sector news Bio Therapeutic Drugs
11:13aGoldman Sachs Adjusts BioNTech's Price Target to $206 from $255, Keeps Neutral Rating
MT
05/23Top Midday Gainers
MT
05/23Catalyst Biosciences Stock Surges After Vertex Pharmaceuticals Buys Catalyst's Compleme..
MT
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform with $738 Price Target
MT
05/23Catalyst Biosciences Shares Soar After Complement Portfolio Sale
DJ
05/23What you need to know about the coronavirus right now
RE
05/23Pfizer, BioNTech Say Third Dose of COVID-19 Vaccine About 80% Effective in Children Age..
MT
05/23Pfizer, BioNTech Publish Data Supporting COVID-19 Vaccine Efficacy In Children Aged Six..
MT
05/23SVB Securities Initiates Gilead Sciences at Market Perform With $68 Price Target
MT
05/23SVB Securities Initiates Regeneron Pharmaceuticals at Outperform With $738 Price Target
MT
05/23SVB Securities Initiates Vertex Pharmaceuticals at Market Perform With $265 Price Targe..
MT
05/23ANALYST RECOMMANDATIONS : AbbVie, Amgen, Caterpillar, HP, Nike...
05/23Regeneron's Phase 3 Trial Data Shows Positive Results for Potential Treatment of Rare H..
MT
05/23VERTEX PHARMACEUTICALS INCORPORATED : VRTX) acquired Complement Portfolio of Catalyst Bio..
CI
05/20Regeneron, Sanofi Receive US FDA Approval of Dupixent for Eosinophilic Esophagitis
MT
05/20Sanofi's Dupixent wins U.S. approval for bigger use
RE
05/20FDA Grants Regeneron Approval for Dupixent in Inflammatory Disorder Treatment
DJ
05/20EU Member States Seek Changes To Supply Contracts For COVID-19 Jabs Amid Declining Dema..
MT
05/19US Health Agency Approves Pfizer-BioNTech's COVID-19 Booster Jab For Children
MT
05/19EU health regulator backs using AstraZeneca COVID shot as booster
RE
05/19European ADRs Move Higher in Thursday Trading
MT
05/19Junshi's COVID-19 Drug Candidate Shows Positive Results in Small Trial; Shares Jump Nea..
MT
05/18Vertex Pharmaceuticals Incorporated Elects Suketu Upadhyay as Independent Director
CI
05/18China Junshi's potential COVID drug shows promise in small trial
RE
05/17Pfizer-BioNTech COVID-19 Vaccine Booster Approved for Children 5 to 11 Years Old in US
MT
05/17UBS Adjusts BioNTech Price Target to $168 From $170, Maintains Neutral Rating
MT
05/17Pfizer, BioNTech Receive US Approval for COVID-19 Jab Booster Dose for Children
MT
05/17Pfizer Gets FDA Emergency Use Authorization for COVID-19 Vaccine as Booster Dose in Chi..
MT
05/17FDA Expands Authorization of Pfizer Covid Booster to Kids 5 to 11
DJ
05/17PRESS RELEASE : Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech..
DJ
05/17Vertex Pharmaceuticals Pledges $50 Million to Health Equity
MT
05/17Vertex Pharmaceuticals Incorporated Announces Further Expansion in the Boston Seaport A..
CI
05/17ANALYST RECOMMENDATIONS : AMD, CarMax, Gilead, J.B. Hunt, Vodafone...
05/17Piper Sandler Adjusts Gilead Sciences' Price Target to $69 From $73, Maintains Neutral ..
MT
05/17WuXi Apptec Eyes Issue of Over 78 Million Shares in Hong Kong Under Mandate
MT
05/16Gilead Sciences Says FDA Lifts Hold on Investigational Lenacapavir to Treat HIV
MT
05/16U.S. Food and Drug Administration Lifts Clinical Hold on Investigational Lenacapavir fo..
CI
05/16Gilead Sciences Says FDA Lifts Clinical Hold On Injectable Lenacapavir
DJ
05/16European ADRs Move Higher in Monday Trading
MT
05/15Pfizer, BioNTech Agree To Move Delivery Schedules For COVID-19 Vaccines In EU
MT
05/13UBS Adjusts Gilead Sciences Price Target to $64 From $65, Maintains Neutral Rating
MT
05/11New class of cancer drugs down, not out, after Roche trial setback - analysts
RE
05/11Pfizer's $11.6 billion Biohaven buy could spark more biotech deals
RE
05/11European ADRs Move Sharply Higher in Wednesday Trading
MT
05/11BIONTECH : Goldman Sachs sticks Neutral
MD
05/10TRANSCRIPT : Gilead Sciences, Inc. Presents at Bank of America 2022 Healthcare Conference,..
CI
05/10TRANSCRIPT : Regeneron Pharmaceuticals, Inc. Presents at Bank of America 2022 Healthcare C..
CI
05/10Morgan Stanley Lowers BioNTech SE's Price Target to $195 From $197, Equalweight Rating ..
MT
05/10What you need to know about the coronavirus right now
RE
05/09BIONTECH : JP Morgan reiterates its Neutral rating
MD
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on Y-MABS THERAPEUTICS, INC.